Evidence exists reporting that underexpression of miR-16 occurs in IBS-D, and miR-16 was involved in barrier function dysregulation through the modulation of Cldn2 and cingulin expression in IBS (6). This evidence concerns the gene CLDN2 and irritable bowel syndrome.